Q2 2025 · 13F-HR
Allostery Investments LPholdings as filed
Filed 2025-08-14 · accession 0001013594-25-001022
$7.9M
Reported value
20
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00370M103 | ABVX | ABIVAX SA | $1.3M | 16.3% | 167,350 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $1.2M | 15.3% | 22,500 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $769,963 | 9.81% | 120,119 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $689,850 | 8.79% | 52,500 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $552,600 | 7.04% | 60,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $532,051 | 6.78% | 119,294 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $473,400 | 6.03% | 9,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $452,200 | 5.76% | 40,000 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $277,629 | 3.54% | 40,353 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $260,580 | 3.32% | 6,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $236,450 | 3.01% | 2,500 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $204,800 | 2.61% | 40,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $172,720 | 2.20% | 4,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $165,200 | 2.10% | 5,000 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $149,602 | 1.91% | 9,356 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $141,960 | 1.81% | 4,000 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $103,360 | 1.32% | 4,000 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $76,303 | 0.97% | 155,720 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $65,850 | 0.84% | 1,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $44,910 | 0.57% | 9,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.